Even before the coronavirus pandemic began, remote healthcare was on the rise. Remote healthcare, which is fast becoming the preferred way to deliver healthcare, has many benefits including reducing costs and freeing up healthcare facilities for critical needs.
It also provides more meaningful and robust data. Many view remote healthcare as more effective and efficient at tracking the health of patients in their natural environment, with physicians noting that more accurate data leads to better outcomes.
Moving standard medical visits online also offers patients more flexibility and physicians more time to prepare for a more efficient and higher value interaction with their patients. This makes remote patient monitoring and remote healthcare in general, a medically and financially effective treatment approach, which also offers better total patient experience.
Despite its pros — more comfort, ease of access, better monitoring and reduced costs — remote healthcare does face some obstacles. To realize its full potential, there are things that need to be sorted out in the remote healthcare market. These things include the following:
Some devices and technology are better suited for experts. As healthcare goes remote, it is important that both med-tech and consumer companies develop technology that can easily be used and accessed by both patients and physicians.
Making easy-to-learn, low-effort and user-friendly technology will not only make it easier for those on board the remote healthcare train to continue using it but also encourage those who are skeptical about it to begin using remote healthcare.
Obtaining care in the hospital setting is often expensive, which is why finding more effective and efficient ways to improve health outcomes is a priority in the clinical world. Embracing a clinical model that doesn’t include a patient being handled in the clinic or a high-cost hospital setting will help deliver cost-effective care, which in turn improves the quality of life and outcomes of patients.
The pandemic brought restrictions and social distancing, but it also prompted people to connect socially online, do business online and even conduct medical functions online. The use of remote connection tools such as Zoom will change clinical-care delivery for the better and bring in many possibilities and benefits in participation care, care access and better outcomes generally. However, hospitals and clinics need to ensure that their teams and technical infrastructure are able to handle the data-management needs for this remote model.
In addition to this, medical providers and hospitals should also ensure that their systems are equipped to handle the anticipated significant volume of patient data and be able to prevent any cyberattacks that may endanger patient information.
As more companies such as RYAH Group Inc. (CSE: RYAH) develop products and software to facilitate telemedicine, a number of the challenges mentioned above will likely be gradually resolved.
NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. are available in the company’s newsroom at https://ibn.fm/RYAH
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
A team of researchers based at the Amsterdam University Medical Center (UMC) have come up…
The global rare disease treatment market was estimated at $195.2 billion in 2024 and is…
Cancer statistics underscore the urgency of ongoing cancer research and the need for more effective…
A team of researchers has leveraged a technique called temporal learning to train an AI…
Sheridan was recently named as a finalist for the 2025 EY Entrepreneur of the Year…
“Research on the treatment of cancer is fundamental to improving outcomes for all patients affected…